Monopar Therapeutics (MNPR) News Today $46.48 -0.77 (-1.63%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$47.74 +1.26 (+2.70%) As of 07/18/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MNPR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 18 at 2:40 AM | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Director Sells $356,160.00 in StockJuly 17 at 9:45 PM | marketbeat.comChristopher M. Starr Sells 16,800 Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR) StockJuly 17 at 9:45 PM | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) CEO Sells $672,000.00 in StockJuly 17 at 9:45 PM | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Director Kim R. Tsuchimoto Sells 8,904 SharesJuly 17 at 6:34 AM | insidertrades.comResearch Analysts Set Expectations for MNPR FY2025 EarningsJuly 11, 2025 | americanbankingnews.comAnalysts Set Expectations for MNPR FY2025 EarningsJuly 9, 2025 | marketbeat.comCantor Fitzgerald Initiates Coverage of Monopar Therapeutics (MNPR) with Overweight RecommendationJuly 8, 2025 | msn.comMonopar Therapeutics (NASDAQ:MNPR) Coverage Initiated by Analysts at Cantor FitzgeraldJuly 7, 2025 | marketbeat.comFY2025 Earnings Forecast for MNPR Issued By Chardan CapitalJune 29, 2025 | marketbeat.comWhat is Chardan Capital's Forecast for MNPR FY2025 Earnings?June 27, 2025 | marketbeat.comChardan Initiates Coverage of Monopar Therapeutics (MNPR) Stock, Gives BuyJune 26, 2025 | finance.yahoo.comInstitutional investors own a significant stake of 29% in Monopar Therapeutics Inc. (NASDAQ:MNPR)June 23, 2025 | finance.yahoo.comChardan Capital Initiates Coverage of Monopar Therapeutics (MNPR) with Buy RecommendationJune 23, 2025 | msn.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Given Average Recommendation of "Moderate Buy" by BrokeragesJune 23, 2025 | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Earns Buy Rating from Analysts at Chardan CapitalJune 23, 2025 | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Trading 0.4% Higher - Time to Buy?June 12, 2025 | marketbeat.comMonopar Therapeutics Inc.: Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced CancersJune 11, 2025 | finanznachrichten.deMonopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced CancersJune 11, 2025 | globenewswire.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Down 13.8% in MayJune 5, 2025 | marketbeat.comMonopar Therapeutics added to Russell 3000 and 2000 indexes, stock up 15%June 3, 2025 | msn.comMonopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® IndexesJune 3, 2025 | globenewswire.comMonopar Therapeutics (NASDAQ:MNPR) Stock Rating Upgraded by Wall Street ZenMay 24, 2025 | marketbeat.comPoint72 Asset Management L.P. Takes Position in Monopar Therapeutics Inc. (NASDAQ:MNPR)May 23, 2025 | marketbeat.comJanus Henderson Group PLC Invests $23.44 Million in Monopar Therapeutics Inc. (NASDAQ:MNPR)May 18, 2025 | marketbeat.comMonopar Therapeutics Reports First Quarter 2025 Financial Results and Recent DevelopmentsMay 13, 2025 | globenewswire.comMonopar Therapeutics Presents Long-Term Efficacy and Safety Data for ALXN1840 in Wilson Disease at EASL International Liver Congress 2025May 8, 2025 | nasdaq.comMonopar Presents ALXN1840 Late-Breaker Data at EASL 2025May 7, 2025 | globenewswire.comGeode Capital Management LLC Acquires 24,530 Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR)May 4, 2025 | marketbeat.comRA Capital Management L.P. Invests $11.25 Million in Monopar Therapeutics Inc. (NASDAQ:MNPR)May 3, 2025 | marketbeat.comMonopar Therapeutics (MNPR) Projected to Post Earnings on ThursdayMay 3, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Takes Position in Monopar Therapeutics Inc. (NASDAQ:MNPR)April 30, 2025 | marketbeat.comMonopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025April 29, 2025 | globenewswire.comPiper Sandler Remains a Buy on Monopar Therapeutics Inc (MNPR)April 14, 2025 | markets.businessinsider.comADAR1 Capital Management LLC Takes $2.86 Million Position in Monopar Therapeutics Inc. (NASDAQ:MNPR)April 9, 2025 | marketbeat.comMonopar Therapeutics Inc. (NASDAQ:MNPR) Major Shareholder Tactic Pharma Llc Sells 33,334 SharesApril 6, 2025 | marketbeat.comQ1 EPS Forecast for Monopar Therapeutics Lowered by AnalystApril 5, 2025 | marketbeat.comTactic Pharma Llc Sells 33,334 Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR) StockApril 5, 2025 | insidertrades.comJones Trading Reaffirms Hold Rating for Monopar Therapeutics (NASDAQ:MNPR)April 4, 2025 | marketbeat.comMonopar Therapeutics (NASDAQ:MNPR) Posts Earnings Results, Misses Estimates By $1.87 EPSApril 3, 2025 | marketbeat.comHC Wainwright Has Negative Outlook of MNPR FY2029 EarningsApril 3, 2025 | marketbeat.comMonopar Therapeutics downgraded to Hold from Buy at JonesResearchApril 2, 2025 | markets.businessinsider.comJones Trading Downgrades Monopar Therapeutics (MNPR)April 2, 2025 | msn.comJonesTrading downgrades Monopar Therapeutics Inc (MNPR) to a HoldApril 2, 2025 | markets.businessinsider.comWe Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business GrowthApril 2, 2025 | finance.yahoo.comHC Wainwright Reiterates "Buy" Rating for Monopar Therapeutics (NASDAQ:MNPR)April 2, 2025 | marketbeat.comMonopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last yearApril 1, 2025 | markets.businessinsider.comMonopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last yearApril 1, 2025 | markets.businessinsider.comMonopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent DevelopmentsMarch 31, 2025 | globenewswire.comMonopar Therapeutics' (MNPR) "Overweight" Rating Reaffirmed at Piper SandlerMarch 20, 2025 | marketbeat.com Get Monopar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MNPR and its competitors with MarketBeat's FREE daily newsletter. Email Address MNPR Media Mentions By Week MNPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNPR News Sentiment▼0.330.59▲Average Medical News Sentiment MNPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNPR Articles This Week▼82▲MNPR Articles Average Week Get Monopar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MNPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Collegium Pharmaceutical News Akebia Therapeutics News Amphastar Pharmaceuticals News Arcus Biosciences News Dyne Therapeutics News Spyre Therapeutics News Verve Therapeutics News Anavex Life Sciences News Mineralys Therapeutics News Avadel Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNPR) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
